Sarepta Therapeutics (SRPT) Stock Highlights

118.97 | -0.42%

2024-12-21 01:06:35

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sareptas strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sareptas product candidates are at an early stage of development.

Statistics

Range Today

118.56 121

Volume Today 1.95M

Range 1 Year

89.92 173.25

Volume 1 Year 305.25M

Range 3 Year

55.25 173.25

Volume 3 Year 886.74M

Range 10 Year

8 181.83

Volume 10 Year 4.06B

Highlights

Market Capitalization 11.62B (large)

Floating Shares 91.14M

Current Price 118.97

Price To Earnings 78.25

Price To Revenue 7.14

Price To Book 9.51

Earnings Per Share 1.54

Payout Ratio 0%

Performance

Latest -0.42%

1 Month +7.7%

3 Months -6.4%

6 Months +1.23%

1 Year +25.83%

3 Years +35.72%

5 Years -5.84%

10 Years +812.35%

Benchmarks

Market Capitalization

12 / 368

Gross Profits

221 / 278

Total Revenue

16 / 300

Total Rank

354 / 368

Free Cashflow

340 / 352

Performance 5 years

126 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.